Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline.
Chest. 2002 Jan;121(1):151-7. doi: 10.1378/chest.121.1.151.
Chest. 2002.
PMID: 11796444
Clinical Trial.